Randomized trial evaluates microbiome signatures for H. pylori classification, suggesting new diagnostic paths.
Helicobacter pylori infection affects approximately 44% of the global population and is causally linked to gastric ulceration and cancer. Standard diagnostic methods detect the pathogen directly, requiring sufficient bacterial load to produce a positive result. This study evaluates whether the surrounding microbiome community structure retains predictive information after removal of direct pathogen-associated features -- a question with implications for community-based infection risk stratification. Using 16S rRNA amplicon sequencing data from 75 gastric microbiome samples, we compare five classifiers across four feature representations: ASV-level taxonomic profiles and PICRUSt2-predicted functional pathway profiles, each evaluated with and without Helicobacter-associated features. Taxonomic features without Helicobacter retained meaningful predictive performance (F1 = 0.693 +/- 0.032), relative to the full feature set (F1 = 0.711 +/- 0.050). Pathway features achieved the strongest overall performance (F1 = 0.721 +/- 0.088). SHAP analysis identified PWY-7373 as the dominant predictive pathway, consistent with known H. pylori sucrose metabolism. Counterfactual perturbation using DiCE identified ARGSYN-PWY and UDPNAGSYN-PWY as candidate metabolic targets, presented as computational hypotheses for further experimental investigation.
No takes yet. Share an insight, caveat, or question.
Hajar Khattabi (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: